CN1604775A - 通过gaba药物调节眼生长和近视 - Google Patents

通过gaba药物调节眼生长和近视 Download PDF

Info

Publication number
CN1604775A
CN1604775A CNA028251512A CN02825151A CN1604775A CN 1604775 A CN1604775 A CN 1604775A CN A028251512 A CNA028251512 A CN A028251512A CN 02825151 A CN02825151 A CN 02825151A CN 1604775 A CN1604775 A CN 1604775A
Authority
CN
China
Prior art keywords
eye
gaba
growth
animal
antagonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA028251512A
Other languages
English (en)
Chinese (zh)
Inventor
R·A·斯通
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pennsylvania Penn
Original Assignee
University of Pennsylvania Penn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Pennsylvania Penn filed Critical University of Pennsylvania Penn
Publication of CN1604775A publication Critical patent/CN1604775A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CNA028251512A 2001-10-16 2002-10-16 通过gaba药物调节眼生长和近视 Pending CN1604775A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32965501P 2001-10-16 2001-10-16
US60/329,655 2001-10-16

Publications (1)

Publication Number Publication Date
CN1604775A true CN1604775A (zh) 2005-04-06

Family

ID=23286413

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA028251512A Pending CN1604775A (zh) 2001-10-16 2002-10-16 通过gaba药物调节眼生长和近视

Country Status (7)

Country Link
US (1) US20060264508A1 (https=)
EP (1) EP1435938A4 (https=)
JP (1) JP2005509623A (https=)
KR (1) KR20040053181A (https=)
CN (1) CN1604775A (https=)
CA (1) CA2466800A1 (https=)
WO (1) WO2003032975A1 (https=)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7266725B2 (en) 2001-09-03 2007-09-04 Pact Xpp Technologies Ag Method for debugging reconfigurable architectures
DE19651075A1 (de) 1996-12-09 1998-06-10 Pact Inf Tech Gmbh Einheit zur Verarbeitung von numerischen und logischen Operationen, zum Einsatz in Prozessoren (CPU's), Mehrrechnersystemen, Datenflußprozessoren (DFP's), digitalen Signal Prozessoren (DSP's) oder dergleichen
DE19654593A1 (de) 1996-12-20 1998-07-02 Pact Inf Tech Gmbh Umkonfigurierungs-Verfahren für programmierbare Bausteine zur Laufzeit
DE19654595A1 (de) 1996-12-20 1998-07-02 Pact Inf Tech Gmbh I0- und Speicherbussystem für DFPs sowie Bausteinen mit zwei- oder mehrdimensionaler programmierbaren Zellstrukturen
EP1329816B1 (de) 1996-12-27 2011-06-22 Richter, Thomas Verfahren zum selbständigen dynamischen Umladen von Datenflussprozessoren (DFPs) sowie Bausteinen mit zwei- oder mehrdimensionalen programmierbaren Zellstrukturen (FPGAs, DPGAs, o.dgl.)
DE19654846A1 (de) 1996-12-27 1998-07-09 Pact Inf Tech Gmbh Verfahren zum selbständigen dynamischen Umladen von Datenflußprozessoren (DFPs) sowie Bausteinen mit zwei- oder mehrdimensionalen programmierbaren Zellstrukturen (FPGAs, DPGAs, o. dgl.)
US6542998B1 (en) 1997-02-08 2003-04-01 Pact Gmbh Method of self-synchronization of configurable elements of a programmable module
DE19704728A1 (de) 1997-02-08 1998-08-13 Pact Inf Tech Gmbh Verfahren zur Selbstsynchronisation von konfigurierbaren Elementen eines programmierbaren Bausteines
DE19704742A1 (de) 1997-02-11 1998-09-24 Pact Inf Tech Gmbh Internes Bussystem für DFPs, sowie Bausteinen mit zwei- oder mehrdimensionalen programmierbaren Zellstrukturen, zur Bewältigung großer Datenmengen mit hohem Vernetzungsaufwand
US8230411B1 (en) 1999-06-10 2012-07-24 Martin Vorbach Method for interleaving a program over a plurality of cells
JP2004506261A (ja) 2000-06-13 2004-02-26 ペーアーツェーテー　イクスペーペー　テクノロジーズ　アクチエンゲゼルシャフト パイプラインｃｔプロトコルおよびｃｔ通信
US8058899B2 (en) 2000-10-06 2011-11-15 Martin Vorbach Logic cell array and bus system
AU2002220600A1 (en) 2000-10-06 2002-04-15 Pact Informationstechnologie Gmbh Cell system with segmented intermediate cell structure
US6990555B2 (en) 2001-01-09 2006-01-24 Pact Xpp Technologies Ag Method of hierarchical caching of configuration data having dataflow processors and modules having two- or multidimensional programmable cell structure (FPGAs, DPGAs, etc.)
US7844796B2 (en) 2001-03-05 2010-11-30 Martin Vorbach Data processing device and method
US7210129B2 (en) 2001-08-16 2007-04-24 Pact Xpp Technologies Ag Method for translating programs for reconfigurable architectures
US7444531B2 (en) 2001-03-05 2008-10-28 Pact Xpp Technologies Ag Methods and devices for treating and processing data
US7581076B2 (en) 2001-03-05 2009-08-25 Pact Xpp Technologies Ag Methods and devices for treating and/or processing data
US7996827B2 (en) 2001-08-16 2011-08-09 Martin Vorbach Method for the translation of programs for reconfigurable architectures
US7434191B2 (en) 2001-09-03 2008-10-07 Pact Xpp Technologies Ag Router
WO2003060747A2 (de) 2002-01-19 2003-07-24 Pact Xpp Technologies Ag Reconfigurierbarer prozessor
EP2043000B1 (de) 2002-02-18 2011-12-21 Richter, Thomas Bussysteme und Rekonfigurationsverfahren
JP2005533082A (ja) * 2002-06-28 2005-11-04 ノバルティス アクチエンゲゼルシャフト 近視の治療のためのｇａｂａ−ｃレセプターアンタゴニストの使用
US7657861B2 (en) 2002-08-07 2010-02-02 Pact Xpp Technologies Ag Method and device for processing data
AU2003286131A1 (en) 2002-08-07 2004-03-19 Pact Xpp Technologies Ag Method and device for processing data
WO2004038599A1 (de) 2002-09-06 2004-05-06 Pact Xpp Technologies Ag Rekonfigurierbare sequenzerstruktur
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds
FI20075498A7 (fi) * 2007-06-29 2008-12-30 Eero Castren Menetelmä amblyopian hoitamiseksi masennuslääkkeillä
WO2015009533A1 (en) 2013-07-16 2015-01-22 Allergan, Inc. Gabaa receptor antagonists affecting ganglion cell function and visual function
US12459965B2 (en) 2017-10-09 2025-11-04 Compass Pathfinder Limited Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
KR20220009954A (ko) 2019-04-17 2022-01-25 컴퍼스 패쓰파인더 리미티드 신경인지 장애, 만성 통증을 치료하고 염증을 감소시키는 방법
CN114306331B (zh) * 2020-10-10 2023-07-18 远大生命科学(武汉)有限公司 戊乙奎醚在治疗或预防视力损伤性眼部疾病中的用途
KR102747804B1 (ko) * 2024-03-07 2024-12-31 주식회사 케이에스비튜젠 라세탐 계열 화합물을 유효성분으로 포함하는 눈 기능 장애 예방, 개선 또는 치료용 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5385939A (en) * 1993-04-30 1995-01-31 The Trustees Of The University Of Pennsylvania GABA-ergic modulation of eye growth

Also Published As

Publication number Publication date
KR20040053181A (ko) 2004-06-23
US20060264508A1 (en) 2006-11-23
EP1435938A4 (en) 2007-12-26
WO2003032975A1 (en) 2003-04-24
JP2005509623A (ja) 2005-04-14
CA2466800A1 (en) 2003-04-24
EP1435938A1 (en) 2004-07-14

Similar Documents

Publication Publication Date Title
CN1604775A (zh) 通过gaba药物调节眼生长和近视
RU2557533C2 (ru) Способы лечения синдрома фибромиалгии
CN101657212B (zh) Trk受体调节剂的使用方法
RU2602738C2 (ru) Комбинация фолиевой кислоты и рамиприла: цитопротекторные, нейропротекторные и ретинопротекторные офтальмологические композиции
CN1582156A (zh) 眼新血管疾病的治疗方法
US12084491B2 (en) Treatment of Parkinson's disease
Qiong et al. Changes in muscarinic acetylcholine receptor expression in form deprivation myopia in guinea pigs
US10888556B2 (en) Method for treating myopia with an nsaid and an anti-muscarinic agent
TWI815423B (zh) 用於治療近視的方法和藥物組合物
JP2018515622A (ja) ニューロン生存因子の相乗組み合わせ及びその使用
US10945980B2 (en) Treatment for myopia
EP2379066A1 (en) Use of opioid antagonists for the preparation of a medicament in the treatment of retinal degenerative diseases
US9072730B2 (en) Method of improving cognitive functions in individuals with down syndrome and/or alzheimer's disease
US20240000891A1 (en) Growth and differentiation factor 15 for treatment of proliferative vitreoretinopathy therapy
HK1075211A (en) Modulation of ocular growth and myopia by gaba drugs
RU2848183C1 (ru) Лечение болезни паркинсона
Marangoni et al. Rearing light intensity affects inner retinal pathology in a mouse model of X-Linked retinoschisis but does not alter gene therapy outcome
WO2025043297A1 (en) Method of treating myopia
Zhang et al. The effect of fingomolid (FTY720) protecting the retina of rats from light-induced retinal degeneration (LIRD)
AU2002362928A1 (en) Modulation of ocular growth and myopia by GABA drugs
HK40114204A (zh) 通过靶向过氧化物酶体增殖物激活受体(ppar)信号通路治疗屈光性疾病
Hertoghe et al. Can-C eye drops–10 years on
Ritchey Regulation of Ocular Growth in Wild-Type and Retinopathy, Globe Enlarged (RGE) Chickens
JP2016147857A (ja) 眼疾患処置薬

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1075211

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1075211

Country of ref document: HK